Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorBartold, Marken
dc.contributor.advisorKardachi, Bryon Joseph Rossen
dc.contributor.advisorHirsch, Robert Stevenen
dc.contributor.authorDoyle, Catherine Janeen
dc.description.abstractAzithromycin is a macrolide antibiotic that is well known for its antibacterial properties, as well as possessing potential anti-inflammatory and immune modulating effects. This antibiotic has therefore been widely used in medicine for treating conditions ranging from inflammatory pulmonary diseases to dermatologic skin conditions. It has also been shown to be an effective antibiotic against most common periodontal pathogens and is used as an adjunct to treat periodontitis, a condition with bacterial aetiology and an inflammatory pathogenesis. Furthermore, periodontal case studies report regeneration of alveolar bone accompanied by significant reductions in inflammation have been achieved with azithromycin. The mechanisms however, by which these are achieved in the periodontium are largely unknown. This study aimed to determine the potential anti-inflammatory effect of azithromycin on cytokine and chemokine production by healthy human gingival fibroblasts (HGFs) that were stimulated by Porphyromonas gingivalis lipopolysaccharide (P. gingivalis LPS). HGFs were isolated from healthy gingiva collected from three donors. The effects of azithromycin at concentrations ranging from 0.1 to 10 μg/mL were tested. Cytokine and chemokine protein levels were assessed using the Luminex® multiplex immunoassay. P. gingivalis LPS induced cytokine/chemokine (IL-6, IL-8, MCP-1 and GRO) protein production in HGFs was suppressed by azithromycin at all concentrations tested, and in all three donors. Suppression by azithromycin of IL-6, IL-8, MCP-1 and GRO P. gingivalis LPS protein induction in HGF was statistically significant when all donor results were collated (p<0.05). This study demonstrates that azithromycin suppresses P. gingivalis LPS induced cytokine/chemokine protein production in HGFs, which may explain some of the clinical benefits observed with the adjunctive use of azithromycin in the treatment of periodontitis.en
dc.subjectazithromycin; periodontitis; human gingival fibroblasts; Porphyromonas gingivalis lipopolysaccharide; cytokine; interleukin-6; interleukin-8; monocyte chemoattractantprotein 1; growth-regulated oncogeneen
dc.titleAzithromycin suppresses P. gingivalis LPS induced pro-inflammatory cytokine and chemokine production (IL-6, IL-8, MCP-1 & GRO) by human gingival fibroblasts in vitro.en
dc.contributor.schoolSchool of Dentistryen
dc.provenanceThis electronic version is made publicly available by the University of Adelaide in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exceptions. If you are the owner of any included third party copyright material you wish to be removed from this electronic version, please complete the take down form located at:
dc.description.dissertationThesis (D.Clin.Dent.) -- University of Adelaide, School of Dentistry, 2014en
Appears in Collections:Research Theses

Files in This Item:
File Description SizeFormat 
01front.pdf418.61 kBAdobe PDFView/Open
02whole.pdf1.64 MBAdobe PDFView/Open
  Restricted Access
Library staff access only1.61 MBAdobe PDFView/Open
  Restricted Access
Library staff access only1.56 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.